Pfizer : PFE

All Pfizer Articles

1490 Articles

Lee Jackson | Oct 1, 2014 at 8:25 AM EDT

Merrill Lynch’s Key Stock Picks for the Fourth Quarter

With or without mid-term elections, the last quarter of 2014 and January of next year could be a bonanza for…

Jon C. Ogg | Sep 25, 2014 at 2:15 PM EDT

5 Defensive Stocks Largely Avoiding the Sell-Off

24/7 Wall St. has tracked several defensive stocks that are not down near as much as the market on Thursday.

Jon C. Ogg | Sep 25, 2014 at 9:50 AM EDT

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.

Jon C. Ogg | Sep 23, 2014 at 1:30 PM EDT

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have…

Paul Ausick | Sep 17, 2014 at 4:06 PM EDT

The 4 Stocks That Boosted the Market

thinkstockSeptember 17, 2014: Markets opened slightly mixed on Wednesday and traded in a narrow range around the break-even line until…

Paul Ausick | Sep 15, 2014 at 4:01 PM EDT

The 4 Stocks That Shored Up the Dow

thinkstockSeptember 15, 2014: Markets opened slightly lower on Monday after the OECD lowered its U.S. GDP growth forecast. The Empire…

Jon C. Ogg | Sep 11, 2014 at 9:05 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data for the August 29 settlement date is out, and we have decided to look at what…

Douglas A. McIntyre | Sep 10, 2014 at 6:41 AM EDT

Facebook More Valuable Than IBM

A great deal was made of the value of Facebook as it crossed the $200 billion market cap level. There…

Trey Thoelcke | Aug 27, 2014 at 1:00 PM EDT

Short Interest Swings in High-Yield Dividend Stocks

4/7 Wall St. reviews short interest in the higher-yield defensive dividend stocks for a sense of what short sellers may…

Paul Ausick | Aug 26, 2014 at 4:01 PM EDT

The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs

thinkstockAugust 26, 2014: Markets opened higher on Tuesday following a huge jump in durable goods orders, a better-than-expected report on…

Chris Lange | Aug 21, 2014 at 2:44 PM EDT

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…

Jon C. Ogg | Aug 18, 2014 at 1:35 PM EDT

3 DJIA Stocks at Real Risk of Hitting 52-Week Lows

Investors seem to have grown accustomed to seeing the Dow Jones Industrial Average (DJIA) hitting new high after new high…

Paul Ausick | Aug 14, 2014 at 4:01 PM EDT

The 4 Stocks That Carried the Market

thinkstockAugust 14, 2014: Markets opened higher on Thursday after a slightly worse-than-expected report on new claims for unemployment benefits. U.S.…

Paul Ausick | Aug 12, 2014 at 4:01 PM EDT

The 4 Stocks That Weighed on the Market

thinkstockAugust 12, 2014: Markets opened lower on Tuesday, took a brief turn into the green, and then settled into the…

Jon C. Ogg | Aug 12, 2014 at 10:42 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data is out for the July 31 settlement date. We often review the higher-yield defensive dividend stocks…

1 … 63 64 65 66 67 … 100

Pfizer : PFE

All Pfizer Articles

Merrill Lynch’s Key Stock Picks for the Fourth Quarter

5 Defensive Stocks Largely Avoiding the Sell-Off

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The 4 Stocks That Boosted the Market

The 4 Stocks That Shored Up the Dow

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

Facebook More Valuable Than IBM

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

3 DJIA Stocks at Real Risk of Hitting 52-Week Lows

The 4 Stocks That Carried the Market

The 4 Stocks That Weighed on the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

66-Year-Old Couple With $2.2M Thought They Were Frugal — Until They Audited Their Spending

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

66-Year-Old Couple With $2.2M Thought They Were Frugal — Until They Audited Their Spending

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

66-Year-Old Couple With $2.2M Thought They Were Frugal — Until They Audited Their Spending

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

Pfizer : PFE

All Pfizer Articles

Merrill Lynch’s Key Stock Picks for the Fourth Quarter

5 Defensive Stocks Largely Avoiding the Sell-Off

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The 4 Stocks That Boosted the Market

The 4 Stocks That Shored Up the Dow

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

Facebook More Valuable Than IBM

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

3 DJIA Stocks at Real Risk of Hitting 52-Week Lows

The 4 Stocks That Carried the Market

The 4 Stocks That Weighed on the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

66-Year-Old Couple With $2.2M Thought They Were Frugal — Until They Audited Their Spending

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

Featured Reads

66-Year-Old Couple With $2.2M Thought They Were Frugal — Until They Audited Their Spending

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback